0 XP   0   0   0

Biotest Aktiengesellschaft










Financial Health of Biotest Aktiengesellschaft




Comparing to competitors in the Other industry




  Industry Rankings  


Richest
#159 / 452

Total Sales
#156 / 452

Making Money
#434 / 452

Working Efficiently
#401 / 452

Biotest Aktiengesellschaft
Buy, Hold or Sell?

Should you buy, hold or sell Biotest Aktiengesellschaft?

I guess you are interested in Biotest Aktiengesellschaft. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Biotest Aktiengesellschaft

Let's start. I'm going to help you getting a better view of Biotest Aktiengesellschaft. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Biotest Aktiengesellschaft even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Biotest Aktiengesellschaft is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Biotest Aktiengesellschaft. The closing price on 2022-11-25 was €43.30 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Biotest Aktiengesellschaft Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

1.1. Profitability of Biotest Aktiengesellschaft.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biotest Aktiengesellschaft earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A Net Profit Margin of -10.9% means that €-0.11 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biotest Aktiengesellschaft:

  • The MRQ is -10.9%. The company is making a huge loss. -2
  • The TTM is -12.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-10.9%TTM-12.1%+1.2%
TTM-12.1%YOY-7.1%-5.0%
TTM-12.1%5Y362.5%-374.6%
5Y362.5%10Y323.5%+39.1%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.9%8.2%-19.1%
TTM-12.1%7.4%-19.5%
YOY-7.1%7.3%-14.4%
5Y362.5%6.7%+355.8%
10Y323.5%6.6%+316.9%
1.1.2. Return on Assets

Shows how efficient Biotest Aktiengesellschaft is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • -1.4% Return on Assets means that Biotest Aktiengesellschaft generated €-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biotest Aktiengesellschaft:

  • The MRQ is -1.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.4%TTM-1.5%+0.1%
TTM-1.5%YOY-0.7%-0.7%
TTM-1.5%5Y-0.4%-1.1%
5Y-0.4%10Y-0.5%+0.1%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.4%1.0%-2.4%
TTM-1.5%1.0%-2.5%
YOY-0.7%0.9%-1.6%
5Y-0.4%0.9%-1.3%
10Y-0.5%0.9%-1.4%
1.1.3. Return on Equity

Shows how efficient Biotest Aktiengesellschaft is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • -4.2% Return on Equity means Biotest Aktiengesellschaft generated €-0.04 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biotest Aktiengesellschaft:

  • The MRQ is -4.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.2%TTM-4.3%+0.1%
TTM-4.3%YOY-1.9%-2.4%
TTM-4.3%5Y-1.0%-3.3%
5Y-1.0%10Y-1.2%+0.2%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.2%3.1%-7.3%
TTM-4.3%2.9%-7.2%
YOY-1.9%2.6%-4.5%
5Y-1.0%2.4%-3.4%
10Y-1.2%2.4%-3.6%

1.2. Operating Efficiency of Biotest Aktiengesellschaft.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biotest Aktiengesellschaft is operating .

  • Measures how much profit Biotest Aktiengesellschaft makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-3.0%+3.0%
TTM-5Y-365.0%+365.0%
5Y-365.0%10Y-327.5%-37.4%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.1%-17.1%
TTM-9.1%-9.1%
YOY-3.0%9.2%-12.2%
5Y-365.0%8.5%-373.5%
10Y-327.5%8.5%-336.0%
1.2.2. Operating Ratio

Measures how efficient Biotest Aktiengesellschaft is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 1.81 means that the operating costs are €1.81 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 1.806. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.928. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.806TTM1.928-0.121
TTM1.928YOY1.792+0.135
TTM1.9285Y1.267+0.661
5Y1.26710Y1.330-0.063
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8061.218+0.588
TTM1.9281.189+0.739
YOY1.7921.203+0.589
5Y1.2671.289-0.022
10Y1.3301.314+0.016

1.3. Liquidity of Biotest Aktiengesellschaft.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biotest Aktiengesellschaft is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 4.27 means the company has €4.27 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 4.272. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.775. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.272TTM4.775-0.504
TTM4.775YOY5.070-0.295
TTM4.7755Y4.090+0.685
5Y4.09010Y3.988+0.102
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2721.491+2.781
TTM4.7751.465+3.310
YOY5.0701.475+3.595
5Y4.0901.299+2.791
10Y3.9881.286+2.702
1.3.2. Quick Ratio

Measures if Biotest Aktiengesellschaft is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A Quick Ratio of 0.94 means the company can pay off €0.94 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.944. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.026. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.944TTM1.026-0.083
TTM1.026YOY1.228-0.202
TTM1.0265Y1.051-0.025
5Y1.05110Y1.060-0.010
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9440.612+0.332
TTM1.0260.602+0.424
YOY1.2280.600+0.628
5Y1.0510.563+0.488
10Y1.0600.552+0.508

1.4. Solvency of Biotest Aktiengesellschaft.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biotest Aktiengesellschaft assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biotest Aktiengesellschaft to Other industry mean.
  • A Debt to Asset Ratio of 0.67 means that Biotest Aktiengesellschaft assets are financed with 67.4% credit (debt) and the remaining percentage (100% - 67.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.674. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.657. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.674TTM0.657+0.017
TTM0.657YOY0.617+0.040
TTM0.6575Y0.613+0.045
5Y0.61310Y0.615-0.002
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6740.562+0.112
TTM0.6570.583+0.074
YOY0.6170.586+0.031
5Y0.6130.583+0.030
10Y0.6150.576+0.039
1.4.2. Debt to Equity Ratio

Measures if Biotest Aktiengesellschaft is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A Debt to Equity ratio of 207.2% means that company has €2.07 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 2.072. The company is just not able to pay all its debts with equity.
  • The TTM is 1.922. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.072TTM1.922+0.150
TTM1.922YOY1.614+0.308
TTM1.9225Y1.617+0.305
5Y1.61710Y1.631-0.014
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0721.244+0.828
TTM1.9221.337+0.585
YOY1.6141.370+0.244
5Y1.6171.439+0.178
10Y1.6311.455+0.176

2. Market Valuation of Biotest Aktiengesellschaft

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Biotest Aktiengesellschaft generates.

  • Above 15 is considered overpriced but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A PE ratio of -110.80 means the investor is paying €-110.80 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is -114.230. Company is losing money. -2
  • The MRQ is -110.800. Company is losing money. -2
  • The TTM is -166.155. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-114.230MRQ-110.800-3.430
MRQ-110.800TTM-166.155+55.355
TTM-166.155YOY608.243-774.398
TTM-166.1555Y66.757-232.912
5Y66.75710Y59.730+7.027
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-114.23036.308-150.538
MRQ-110.80038.458-149.258
TTM-166.15544.588-210.743
YOY608.24348.072+560.171
5Y66.75740.090+26.667
10Y59.73041.443+18.287
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Biotest Aktiengesellschaft.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 164.555. Seems overpriced? -1
  • The TTM is 115.486. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ164.555TTM115.486+49.069
TTM115.486YOY32.624+82.862
TTM115.4865Y83.441+32.045
5Y83.44110Y83.4410.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ164.5550.154+164.401
TTM115.4860.050+115.436
YOY32.6240.186+32.438
5Y83.4410.158+83.283
10Y83.4410.155+83.286

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biotest Aktiengesellschaft is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 4.63 means the investor is paying €4.63 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is 4.777. Neutral. Compare to industry.
  • The MRQ is 4.633. Neutral. Compare to industry.
  • The TTM is 4.398. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD4.777MRQ4.633+0.143
MRQ4.633TTM4.398+0.236
TTM4.398YOY2.703+1.694
TTM4.3985Y1.964+2.433
5Y1.96410Y1.757+0.207
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD4.7771.411+3.366
MRQ4.6331.419+3.214
TTM4.3981.575+2.823
YOY2.7031.352+1.351
5Y1.9641.288+0.676
10Y1.7571.330+0.427
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Biotest Aktiengesellschaft compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.414-0.402-3%-0.233-44%0.824-150%0.824-150%
Book Value Growth---0.088-0.084-4%-0.063-29%-0.041-53%-0.041-54%
Book Value Per Share--9.0659.643-6%10.967-17%6.934+31%6.204+46%
Book Value Per Share Growth---0.046-0.042-8%-0.021-54%0.064-171%0.064-171%
Current Ratio--4.2724.775-11%5.070-16%4.090+4%3.988+7%
Debt To Asset Ratio--0.6740.657+3%0.617+9%0.613+10%0.615+10%
Debt To Equity Ratio--2.0721.922+8%1.614+28%1.617+28%1.631+27%
Dividend Per Share----0%-0%-0%-0%
Eps---0.379-0.411+8%-0.208-45%-0.173-54%-0.155-59%
Eps Growth---0.6731.046-164%9.886-107%3.887-117%3.887-117%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---0.109-0.121+11%-0.071-35%3.625-103%3.235-103%
Operating Margin----0%-0.0300%-3.6500%-3.2750%
Operating Ratio--1.8061.928-6%1.792+1%1.267+43%1.330+36%
Pb Ratio4.777+3%4.6334.398+5%2.703+71%1.964+136%1.757+164%
Pe Ratio-114.230-3%-110.800-166.155+50%608.243-118%66.757-266%59.730-286%
Peg Ratio--164.555115.486+42%32.624+404%83.441+97%83.441+97%
Price Per Share43.300+3%42.00042.325-1%29.575+42%29.025+45%28.760+46%
Price To Total Gains Ratio-104.478-3%-101.342-158.261+56%-212.642+110%-152.148+50%-152.148+50%
Profit Growth---66.010112.876-158%1030.683-106%129.249-151%149.234-144%
Quick Ratio--0.9441.026-8%1.228-23%1.051-10%1.060-11%
Return On Assets---0.014-0.015+8%-0.007-47%-0.004-72%-0.005-67%
Return On Equity---0.042-0.043+3%-0.019-55%-0.010-76%-0.012-72%
Revenue Growth--0.121-0.064+153%-0.064+153%-26.583+22063%-25.097+20835%
Total Gains Per Share---0.414-0.402-3%-0.233-44%0.824-150%0.824-150%
Total Gains Per Share Growth---0.6770.791-186%1.269-153%-3.678+443%-3.678+443%
Usd Book Value--373227350.000397054800.000-6%451550987.500-17%438589111.765-15%429408873.684-13%
Usd Book Value Change Per Share---0.431-0.419-3%-0.243-44%0.857-150%0.857-150%
Usd Book Value Per Share--9.43210.034-6%11.411-17%7.215+31%6.456+46%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.394-0.428+9%-0.216-45%-0.180-54%-0.161-59%
Usd Price Per Share45.054+3%43.70144.039-1%30.773+42%30.200+45%29.925+46%
Usd Profit---15607500.000-16934137.500+9%-8558112.500-45%-4774058.824-69%-5246310.526-66%
Usd Revenue--142756600.000132897862.500+7%131935400.000+8%115740323.529+23%117089107.895+22%
Usd Total Gains Per Share---0.431-0.419-3%-0.243-44%0.857-150%0.857-150%
 EOD+2 -3MRQTTM+11 -20YOY+5 -265Y+9 -2210Y+9 -22

3.2. Fundamental Score

Let's check the fundamental score of Biotest Aktiengesellschaft based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-114.230
Price to Book Ratio (EOD)Between0-14.777
Net Profit Margin (MRQ)Greater than0-0.109
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.944
Current Ratio (MRQ)Greater than14.272
Debt to Asset Ratio (MRQ)Less than10.674
Debt to Equity Ratio (MRQ)Less than12.072
Return on Equity (MRQ)Greater than0.15-0.042
Return on Assets (MRQ)Greater than0.05-0.014
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Biotest Aktiengesellschaft based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.338
Ma 20Greater thanMa 5042.310
Ma 50Greater thanMa 10041.896
Ma 100Greater thanMa 20041.969
OpenGreater thanClose42.600
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets1,101,900
Total Liabilities743,200
Total Stockholder Equity358,700
 As reported
Total Liabilities 743,200
Total Stockholder Equity+ 358,700
Total Assets = 1,101,900

Assets

Total Assets1,101,900
Total Current Assets522,000
Long-term Assets522,000
Total Current Assets
Cash And Cash Equivalents 85,000
Short-term Investments 18,100
Net Receivables 97,200
Inventory 263,200
Other Current Assets 15,400
Total Current Assets  (as reported)522,000
Total Current Assets  (calculated)478,900
+/- 43,100
Long-term Assets
Long-term Assets Other 300
Long-term Assets  (as reported)579,900
Long-term Assets  (calculated)300
+/- 579,600

Liabilities & Shareholders' Equity

Total Current Liabilities122,200
Long-term Liabilities621,000
Total Stockholder Equity358,700
Total Current Liabilities
Accounts payable 42,200
Other Current Liabilities 18,900
Total Current Liabilities  (as reported)122,200
Total Current Liabilities  (calculated)61,100
+/- 61,100
Long-term Liabilities
Long-term Liabilities  (as reported)621,000
Long-term Liabilities  (calculated)0
+/- 621,000
Total Stockholder Equity
Retained Earnings 99,300
Total Stockholder Equity (as reported)358,700
Total Stockholder Equity (calculated)99,300
+/- 259,400
Other
Capital Stock39,600
Common Stock Shares Outstanding 39,571
Net Invested Capital 358,700
Net Working Capital 399,800



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
889,200
967,100
953,600
978,500
1,017,200
1,044,600
1,058,200
1,091,000
1,108,400
1,107,600
1,145,200
1,122,200
1,131,300
1,134,800
1,145,800
1,135,400
1,104,200
1,109,800
1,101,900
1,101,9001,109,8001,104,2001,135,4001,145,8001,134,8001,131,3001,122,2001,145,2001,107,6001,108,4001,091,0001,058,2001,044,6001,017,200978,500953,600967,100889,200
   > Total Current Assets 
392,000
396,500
368,800
449,700
487,600
476,100
488,600
508,500
522,800
525,600
563,900
542,200
556,300
560,600
570,500
556,600
522,200
523,900
522,000
522,000523,900522,200556,600570,500560,600556,300542,200563,900525,600522,800508,500488,600476,100487,600449,700368,800396,500392,000
       Cash And Cash Equivalents 
38,100
62,800
30,900
22,300
42,700
43,400
49,800
65,500
60,800
44,000
63,700
40,200
71,300
55,000
72,000
79,200
104,400
115,300
85,000
85,000115,300104,40079,20072,00055,00071,30040,20063,70044,00060,80065,50049,80043,40042,70022,30030,90062,80038,100
       Short-term Investments 
10,800
1,600
1,100
0
128,900
52,500
31,900
34,100
24,900
20,600
31,000
32,800
17,900
13,300
13,100
12,100
13,100
14,800
18,100
18,10014,80013,10012,10013,10013,30017,90032,80031,00020,60024,90034,10031,90052,500128,90001,1001,60010,800
       Net Receivables 
128,400
148,200
153,200
152,500
139,900
94,200
108,400
104,800
107,700
93,300
112,600
108,900
115,800
122,400
115,100
107,400
107,300
86,200
97,200
97,20086,200107,300107,400115,100122,400115,800108,900112,60093,300107,700104,800108,40094,200139,900152,500153,200148,200128,400
       Inventory 
167,200
170,700
169,900
146,900
165,100
236,000
247,000
257,300
280,100
312,400
304,300
306,900
290,100
301,800
303,100
298,100
244,600
255,800
263,200
263,200255,800244,600298,100303,100301,800290,100306,900304,300312,400280,100257,300247,000236,000165,100146,900169,900170,700167,200
       Other Current Assets 
47,500
13,200
13,700
127,400
11,000
12,900
10,100
6,900
1,400
9,600
8,400
9,700
1,200
18,700
13,400
12,100
3,100
18,000
15,400
15,40018,0003,10012,10013,40018,7001,2009,7008,4009,6001,4006,90010,10012,90011,000127,40013,70013,20047,500
   > Long-term Assets 
0
0
0
0
0
568,500
569,600
582,500
585,600
582,000
581,300
580,000
575,000
574,200
575,300
578,800
582,000
585,900
579,900
579,900585,900582,000578,800575,300574,200575,000580,000581,300582,000585,600582,500569,600568,50000000
       Property Plant Equipment 
436,700
455,700
475,500
298,700
487,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000487,900298,700475,500455,700436,700
       Goodwill 
0
0
0
7,300
0
0
0
0
7,200
0
0
0
7,100
0
0
0
7,100
0
0
007,1000007,1000007,20000007,300000
       Long Term Investments 
5,800
55,500
47,100
2,300
2,700
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000002,7002,30047,10055,5005,800
       Intangible Assets 
24,800
24,100
24,300
4,000
16,200
0
0
0
6,600
0
0
0
6,900
0
0
0
4,100
0
0
004,1000006,9000006,60000016,2004,00024,30024,10024,800
       Long-term Assets Other 
0
0
0
0
0
100
569,600
7,700
100
5,600
3,600
3,700
100
300
100
100
400
500
300
3005004001001003001003,7003,6005,6001007,700569,60010000000
> Total Liabilities 
553,300
627,600
622,200
630,700
677,100
550,700
562,000
599,300
631,500
641,400
685,900
678,000
689,700
707,100
723,400
723,200
723,800
734,700
743,200
743,200734,700723,800723,200723,400707,100689,700678,000685,900641,400631,500599,300562,000550,700677,100630,700622,200627,600553,300
   > Total Current Liabilities 
118,500
135,100
136,500
251,200
385,000
107,800
415,600
101,100
115,000
123,100
113,800
103,300
105,600
121,100
111,100
103,800
106,400
114,900
122,200
122,200114,900106,400103,800111,100121,100105,600103,300113,800123,100115,000101,100415,600107,800385,000251,200136,500135,100118,500
       Short-term Debt 
350,500
414,300
412,400
406,400
471,300
0
0
0
3,300
0
0
0
0
0
0
0
0
0
0
00000000003,300000471,300406,400412,400414,300350,500
       Short Long Term Debt 
350,500
414,300
412,400
406,400
471,300
0
0
0
3,300
0
0
0
3,500
0
0
0
1,600
0
0
001,6000003,5000003,300000471,300406,400412,400414,300350,500
       Accounts payable 
43,500
56,000
49,400
65,000
41,600
50,600
63,300
40,100
52,200
54,700
49,000
37,700
42,000
49,300
43,800
31,500
38,800
38,700
42,200
42,20038,70038,80031,50043,80049,30042,00037,70049,00054,70052,20040,10063,30050,60041,60065,00049,40056,00043,500
       Other Current Liabilities 
57,800
61,200
63,200
66,600
73,500
25,700
28,900
30,400
7,700
33,100
34,700
33,500
5,900
35,400
39,100
39,500
4,300
14,900
18,900
18,90014,9004,30039,50039,10035,4005,90033,50034,70033,1007,70030,40028,90025,70073,50066,60063,20061,20057,800
   > Long-term Liabilities 
0
0
0
0
0
442,900
146,400
498,200
516,500
518,300
572,100
574,700
584,100
586,000
612,300
619,400
617,400
619,800
621,000
621,000619,800617,400619,400612,300586,000584,100574,700572,100518,300516,500498,200146,400442,90000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
26,700
0
0
0
27,400
0
0
0
26,800
0
0
0026,80000027,40000026,70000000000
       Long-term Liabilities Other 
0
0
0
0
0
100
200
200
300
100
0
0
-600
0
0
0
-1,900
0
0
00-1,900000-6000010030020020010000000
> Total Stockholder Equity
335,700
339,300
331,200
347,600
339,900
493,900
496,200
491,700
476,900
466,200
459,300
444,200
441,600
427,700
422,400
412,200
380,400
375,100
358,700
358,700375,100380,400412,200422,400427,700441,600444,200459,300466,200476,900491,700496,200493,900339,900347,600331,200339,300335,700
   Common Stock
39,600
39,600
39,600
39,600
39,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000039,60039,60039,60039,60039,600
   Retained Earnings 
76,300
45,700
71,800
58,300
80,500
52,900
234,800
232,300
217,500
206,800
199,900
184,800
182,200
168,300
163,000
152,800
121,000
115,700
99,300
99,300115,700121,000152,800163,000168,300182,200184,800199,900206,800217,500232,300234,80052,90080,50058,30071,80045,70076,300
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
0
34,200
0
29,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000029,900034,2000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue515,600
Cost of Revenue-434,900
Gross Profit80,70080,700
 
Operating Income (+$)
Gross Profit80,700
Operating Expense-567,700
Operating Income-52,100-487,000
 
Operating Expense (+$)
Research Development52,300
Selling General Administrative81,200
Selling And Marketing Expenses-
Operating Expense567,700133,500
 
Net Interest Income (+$)
Interest Income200
Interest Expense-13,200
Net Interest Income-15,700-13,000
 
Pretax Income (+$)
Operating Income-52,100
Net Interest Income-15,700
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-62,600-52,100
EBIT - interestExpense = -13,200
-63,400
-50,200
Interest Expense13,200
Earnings Before Interest and Taxes (ebit)--49,400
Earnings Before Interest and Taxes (ebitda)-18,300
 
After tax Income (+$)
Income Before Tax-62,600
Tax Provision-700
Net Income From Continuing Ops-63,400-63,300
Net Income-63,400
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-15,700
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
GBPTWD.FOREX
29 minutes ago

I found you a Golden Cross on the daily chart of GBPTWD.FOREX.

GBPTWD.FOREX Daily Candlestick Chart
MYRCNH.FOREX
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MYRCNH.FOREX.

MYRCNH.FOREX Daily Candlestick Chart
CNHTHB.FOREX
30 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CNHTHB.FOREX.

CNHTHB.FOREX Daily Candlestick Chart
AEDNZD.FOREX
30 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AEDNZD.FOREX.

AEDNZD.FOREX Daily Candlestick Chart
EURCAD.FOREX
34 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of EURCAD.FOREX.

EURCAD.FOREX Daily Candlestick Chart
DKKPKR.FOREX
35 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DKKPKR.FOREX.

DKKPKR.FOREX Daily Candlestick Chart
CEY.NASDAQ
44 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CEY.NASDAQ.

CEY.NASDAQ Daily Candlestick Chart
QINT.NYSE ARC
45 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of QINT.NYSE ARC.

QINT.NYSE ARC Daily Candlestick Chart
BNKU.NYSE ARC
45 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of BNKU.NYSE ARC.

BNKU.NYSE ARC Daily Candlestick Chart
BNKD.NYSE ARC
45 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of BNKD.NYSE ARC.

BNKD.NYSE ARC Daily Candlestick Chart
BBJP.BATS
46 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BBJP.BATS.

BBJP.BATS Daily Candlestick Chart
SIXH.NYSE ARC
46 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SIXH.NYSE ARC.

SIXH.NYSE ARC Daily Candlestick Chart
OVF.NYSE ARC
46 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OVF.NYSE ARC.

OVF.NYSE ARC Daily Candlestick Chart
LCTD.NYSE ARC
47 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of LCTD.NYSE ARC.

LCTD.NYSE ARC Daily Candlestick Chart
KHYB.NYSE ARC
47 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of KHYB.NYSE ARC.

KHYB.NYSE ARC Daily Candlestick Chart
KNG.BATS
48 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of KNG.BATS.

KNG.BATS Daily Candlestick Chart
BPS-PU.TO
49 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BPS-PU.TO.

BPS-PU.TO Daily Candlestick Chart
AVDV.NYSE ARC
49 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AVDV.NYSE ARC.

AVDV.NYSE ARC Daily Candlestick Chart
AVDE.NYSE ARC
49 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AVDE.NYSE ARC.

AVDE.NYSE ARC Daily Candlestick Chart
ESALY.PINK
50 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ESALY.PINK.

ESALY.PINK Daily Candlestick Chart
ENGIY.PINK
50 minutes ago

I found you a Golden Cross on the daily chart of ENGIY.PINK.

ENGIY.PINK Daily Candlestick Chart
WDIV.NYSE ARC
51 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of WDIV.NYSE ARC.

WDIV.NYSE ARC Daily Candlestick Chart
VYMI.NASDAQ
51 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VYMI.NASDAQ.

VYMI.NASDAQ Daily Candlestick Chart
VTV.NYSE ARC
51 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VTV.NYSE ARC.

VTV.NYSE ARC Daily Candlestick Chart
VIGI.NASDAQ
52 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VIGI.NASDAQ.

VIGI.NASDAQ Daily Candlestick Chart